Artificial Intelligence and Big Data will be the two most impactful technologies for the pharmaceutical industry for the fourth year in a row in 2023, according to a survey by GlobalData.
GlobalData’s “The State of the Biopharmaceutical Industry – 2023” reveals that AI and Big Data have been trending as the two most disruptive emerging technologies since 2020, with a significant margin from the third choice in all four years.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Asian stocks slip as cautious investors await rates decisionsBig week includes central bank meetings and batch of earnings reports and economic data
Source: BDliveSA - 🏆 12. / 63 Read more »